II. Indications
III. Contraindications
IV. Mechanism
V. Medicatons
- See oral and intravenous dosing below
-
Generic Levothyroxine is of similar quality to brand drugs
- However agents from different manufacturers are not bioequivalent
- When manufacturer changes, recheck TSH level in 6 to 8 weeks after change
- Levothyroxine alone is the only recommended replacement strategy
- T4 is converted in peripheral tissues to T3
- T3-T4 combination is not recommended
- Desiccated Thyroid Hormone is not recommended
- Grozinsky-Glasberg (2006) J Clin Endocrinol Metab 91(7): 2592-9 [PubMed]
- Available Formulations
- Capsules are also available under the trade name Tirosint
- Levothyroxine Tablets: 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 and 300 mcg
- Tablets may be crushed for use in infants and children
VI. Dosing: Oral
- Use lower dosing in Subclinical Hypothyroidism
- Dosing precautions
- Take Levothyroxine at a consistent time each day
- However, any time of day is just as efficacious as another
- Doses should be taken 1 hour before a meal or 4 hours after the last meal (e.g. at bedtime) to maximize absorption
- Commonly taken before breakfast or at bedtime
- However, consistently taking Levothyroxine in the same way every day is more important than an empty Stomach
- If patient can only take at mealtime, then consistently take with meals and adjust dosing
- Avoid within 4 hours of products that decrease Levothyroxine absorption (e.g. Calcium, iron, Multivitamins)
- See Drug Interactions above
- Take Levothyroxine at a consistent time each day
- Anticipated total dose (50 to 200 mcg/day in adults, maximum 300 mg/day)
- Child 0 to 6 months: 8 to 10 mcg/kg/day orally daily
- Child 6 to 12 months: 6 to 8 mcg/kg/day orally daily
- Child 1 to 5 years: 5 to 6 mcg/kg/day orally daily
- Child 6 to 12 years: 4 to 5 mcg/kg/day orally daily
- Child >12 years: 2 to 3 mcg/kg/day orally daily
- Adults: 1.6 mcg/kg/day (1.5 to 1.8 mcg/kg/day, or roughly 1 mcg/lb)
- Elderly: 1 mcg/kg/day
- Younger persons (no comorbid conditions)
- Usual starting dose: 75 to 100 mcg daily
- Options for initiating dosing
- Option 1
- Start at 75 to 100 mcg daily
- Option 2
- Start at 0.8 mcg/kg/day (50% of anticipated dose)
- Increase to 1.6 mcg/kg/day at 2 weeks
- Option 1
- Titrate dose based on Thyroid Stimulating Hormone
- Adjust dose by 12.5 to 25 mcg increments every 6 weeks until full replacement dose reached
- Typical dose
- Range: 100 to 200 mcg/day
- Maximum: 300 mcg/day
- Age over 50 years or history of heart disease
- Start at 25-50 mcg daily
- Adjust dose by 12.5 to 25 mcg increments every 6 weeks until full replacement dose reached
- Follow Thyroid Stimulating Hormone (TSH) closely
- Pregnancy
- See Hypothyroidism in Pregnancy
- Maintaining euthyroid state in pregnancy is critical
VII. Dosing: Intravenous dosing
- Maintenance (patient unable to take oral dose for >7 days)
- Parenteral dose is 70-80% of usual oral dose
-
Myxedema Coma (Hypothyroid Coma)
- Load 300 to 500 mcg IV once
- Next: 50 to 100 mcg IV daily until patient able to take oral dosing
VIII. Adverse Effects: Excessive Thyroid Replacement
- Osteoporosis
- Atrial Fibrillation
- Cardiac hypertrophy
- Increased Intraventricular septum thickness
- Increased Left Ventricular posterior wall thickness
- Increased End Diastolic Dimension
- Increased Left Ventricular Mass Index
- Decreased Exercise Tolerance
- Decreased VO2 Max
- Decreased Anaerobic threshold
IX. Safety
- Considered safe in Lactation
- Considered safe in pregnancy
- See Hypothyroidism in Pregnancy
- Maintaining euthyroid state in pregnancy is critical
X. Monitoring
- Protocols for monitoring
- Monitoring every 6 to 8 weeks
- TSH not yet stabilized after initiation
- Recent change in Thyroid Replacement dosing
- Recent change in manufacturer
- Consider monitoring less frequently than annually (usually done annually in this group)
- Requires dose stable
- Age under 50 years with weight stable
- No comorbid condition
- Levothyroxine dose 125 mcg or less
- Pecina (2014) Am J Med 127(3): 240-5 [PubMed]
- Monitoring at least annually (when on stable dose)
- Age over 50 years
- Weight change
- Monitoring every 6 to 8 weeks
- Specific Testing
- Thyroid Stimulating Hormone
- Lags Levothyroxine dose change by 6 weeks
- Target adjusting TSH to the normal mid-range (<3 mg/dl)
- Thyroxine (T4)
- Lags Levothyroxine dose change by 1-2 weeks
- Thyroid Stimulating Hormone
XI. Drug Interactions (Take 4 hours apart)
- Foods that interfere with Levothyroxine absorption (lower levels)
- Regular use of these foods may require increased dose
- Grapefruit should be avoided regardless of time taken
- Walnuts
- Dietary Fiber
- Soy products including soybean flour
- Interfere with GI absorption (lower levels)
- Increase metabolism of Thyroxine (lowers levels)
- Medications interfere with T4 production and T3 conversion (lower levels)
- Lithium
- Amiodarone
- Medications containing Iodine
- Beta Adrenergic Agonists
- Glucocorticoids
- Medications increasing Protein binding (lowers levels)
- Pregnancy (high Estrogenic state)
- Oral Contraceptive
- Estrogen Replacement
- Medications decreasing Protein binding (raises levels)
- Furosemide (Lasix)
- Mefenamic Acid (Ponstel)
- Salicylates
- Androgens
- Decreased Serum Proteins with aging
- Nephrotic Syndrome
- Cirrhosis
- Protein-losing Enteropathy
XII. Resources
- Levothyroxine (DailyMed)
XIII. References
- (2023) Presc Lett 30(7): 39-40
- Svec (2001) CMEA Medicine Lecture, San Diego
- Dong (1997) JAMA, 277:1205-13 [PubMed]
- Hueston (2001) Am Fam Physician 64:1717-24 [PubMed]
- Jonklaas (2014) Thyroid 24(12):1670-751 +PMID:25266247 [PubMed]
- Mercuro (2000) J Clin Endocrinol Metab 85:159 [PubMed]
- Singer (1995) JAMA 273:808-12 [PubMed]
- Surks (1995) N Engl J Med 333:1688-94 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
levothyroxine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LEVOTHYROXINE 100 MCG CAPSULE | Generic | $3.83 each |
LEVOTHYROXINE 100 MCG TABLET | Generic | $0.11 each |
LEVOTHYROXINE 112 MCG TABLET | Generic | $0.15 each |
LEVOTHYROXINE 125 MCG CAPSULE | Generic | $3.99 each |
LEVOTHYROXINE 125 MCG TABLET | Generic | $0.14 each |
LEVOTHYROXINE 137 MCG CAPSULE | Generic | $3.53 each |
LEVOTHYROXINE 137 MCG TABLET | Generic | $0.14 each |
LEVOTHYROXINE 150 MCG TABLET | Generic | $0.14 each |
LEVOTHYROXINE 175 MCG TABLET | Generic | $0.18 each |
LEVOTHYROXINE 200 MCG TABLET | Generic | $0.14 each |
LEVOTHYROXINE 25 MCG CAPSULE | Generic | $3.97 each |
LEVOTHYROXINE 25 MCG TABLET | Generic | $0.09 each |
LEVOTHYROXINE 300 MCG TABLET | Generic | $0.16 each |
LEVOTHYROXINE 50 MCG CAPSULE | Generic | $3.97 each |
LEVOTHYROXINE 50 MCG TABLET | Generic | $0.10 each |
LEVOTHYROXINE 75 MCG CAPSULE | Generic | $4.01 each |
LEVOTHYROXINE 75 MCG TABLET | Generic | $0.12 each |
LEVOTHYROXINE 88 MCG CAPSULE | Generic | $3.62 each |
LEVOTHYROXINE 88 MCG TABLET | Generic | $0.12 each |
synthroid (on 1/14/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
SYNTHROID 100 MCG TABLET | Generic | $0.11 each |
SYNTHROID 112 MCG TABLET | Generic | $0.15 each |
SYNTHROID 125 MCG TABLET | Generic | $0.14 each |
SYNTHROID 137 MCG TABLET | Generic | $0.14 each |
SYNTHROID 150 MCG TABLET | Generic | $0.14 each |
SYNTHROID 175 MCG TABLET | Generic | $0.18 each |
SYNTHROID 200 MCG TABLET | Generic | $0.14 each |
SYNTHROID 25 MCG TABLET | Generic | $0.09 each |
SYNTHROID 300 MCG TABLET | Generic | $0.16 each |
SYNTHROID 50 MCG TABLET | Generic | $0.10 each |
SYNTHROID 75 MCG TABLET | Generic | $0.12 each |
SYNTHROID 88 MCG TABLET | Generic | $0.12 each |
tirosint (on 7/20/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
TIROSINT 100 MCG CAPSULE | Generic | $3.83 each |
TIROSINT 112 MCG CAPSULE | $4.24 each | |
TIROSINT 125 MCG CAPSULE | $4.27 each | |
TIROSINT 13 MCG CAPSULE | $4.24 each | |
TIROSINT 137 MCG CAPSULE | $4.24 each | |
TIROSINT 150 MCG CAPSULE | $4.26 each | |
TIROSINT 175 MCG CAPSULE | $4.28 each | |
TIROSINT 200 MCG CAPSULE | $4.29 each | |
TIROSINT 25 MCG CAPSULE | Generic | $3.97 each |
TIROSINT 50 MCG CAPSULE | Generic | $3.97 each |
TIROSINT 75 MCG CAPSULE | $4.25 each | |
TIROSINT 88 MCG CAPSULE | $4.24 each | |
TIROSINT-SOL 200 MCG/ML SOLN | $4.23 per ml | |
TIROSINT-SOL 50 MCG/ML SOLN | $4.27 per ml | |
unithroid (on 6/22/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
UNITHROID 100 MCG TABLET | Generic | $0.11 each |
UNITHROID 112 MCG TABLET | Generic | $0.15 each |
UNITHROID 125 MCG TABLET | Generic | $0.14 each |
UNITHROID 137 MCG TABLET | Generic | $0.09 each |
UNITHROID 150 MCG TABLET | Generic | $0.14 each |
UNITHROID 175 MCG TABLET | Generic | $0.19 each |
UNITHROID 50 MCG TABLET | Generic | $0.10 each |
UNITHROID 75 MCG TABLET | Generic | $0.12 each |
UNITHROID 88 MCG TABLET | Generic | $0.12 each |
Ontology: Levothyroxine Sodium (C0079691)
Definition (NCI) | The sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland. In peripheral tissues, levothyroxine is deiodinated by 5'-deiodinase to form triiodothyronine (T3). T3 enters the cell and binds to nuclear thyroid hormone receptors; the activated hormone-receptor complex in turn triggers gene expression and produces proteins required in the regulation of cellular respiration; thermogenesis; cellular growth and differentiation; and the metabolism of proteins, carbohydrates and lipids. T3 also exhibits cardiostimulatory effects. |
Definition (PDQ) | The sodium salt form of levothyroxine, a synthetic levoisomer of thyroxine (T4), similar to the endogenous hormone produced by the thyroid gland. Thyroxine is de-iodinated to form triiodothyronine (T3) in the peripheral tissues. T3 enters the cell and binds to nuclear thyroid hormone receptors, and the hormone-receptor complex in turn triggers gene expression and produces proteins required in the regulation of cellular respiration, thermogenesis, cellular growth and differentiation, and metabolism of proteins, carbohydrates and lipids. T4 and T3 also posses cardiac stimulatory effect. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39117&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39117&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C888" NCI Thesaurus) |
Concepts | Pharmacologic Substance (T121) , Amino Acid, Peptide, or Protein (T116) , Hormone (T125) |
MSH | D013974 |
SnomedCT | 26456008, 325317009, 126202002, 38076006 |
English | Sodium Levothyroxine, T4 thyroxine sodium preparation, T<sub>4</sub> thyroxine sodium preparation, levothyroxine sodium, Therapeutic Levothyroxine, LEVOTHYROXINE SODIUM, sodium levothyroxine (medication), thyroid preparations sodium levothyroxine, sodium levothyroxine, thyroid preparations sodium levothyroxine (Synthroid, IV), Levothyroxine Sodium [Chemical/Ingredient], sodium thyroxine, thyroxine sodium, LEVOTHYROXINE sodium, Thyroxine sodium (product), Sodium levothyroxine, Thyroxine sodium, L-thyroxine sodium preparation, Levothyroxine sodium preparation, Sodium thyroxine, Levothyroxine sodium, T>4< thyroxine sodium preparation, Laevothyroxine sodium preparation, Laevothyroxine sodium, Levothyroxine sodium (substance), Levothyroxine sodium preparation (product), Levothyroxine Sodium, Levothyroxine sodium preparation (substance), Thyroxine sodium (substance) |
Spanish | preparado de T4 tiroxina sódica, preparado de L-tiroxina sódica, preparado con levotiroxina sódica (producto), preparado de T>4< tiroxina sódica, T4 tiroxina sódica, T<sub>4</sub> tiroxina sódica, preparado de T<sub>4</sub> tiroxina sódica, T>4< tiroxina sódica, levotiroxina sódica (producto), preparado con levotiroxina sódica, tiroxina sódica (producto), tiroxina sódica, levotiroxina sódica (sustancia), levotiroxina sódica, preparado de levotiroxina sódica (producto), preparado de levotiroxina sódica (sustancia), preparado de levotiroxina sódica |
French | Lévothyroxine sodique |
Norwegian | Levotyroksinnatrium, Natrium-levotyroksin |
Ontology: Synthroid (C0728762)
Definition (CHV) | thyroid hormone in a drug form |
Concepts | Pharmacologic Substance (T121) , Amino Acid, Peptide, or Protein (T116) |
MSH | D013974 |
French | Synthroid |
English | synthroid, Abbot Brand of Levothyroxine Sodium, Synthroid |
Norwegian | Synthroid |
Ontology: Thyroid hormone replacement therapy (C2242640)
Concepts | Therapeutic or Preventive Procedure (T061) |
English | Thyroid hormone replacement therapy |
Spanish | Tratamiento de sustitución de hormona tiroidea |
Dutch | schildklierhormoonvervangingstherapie |
German | Schilddruesenhormonsubstitutionstherapie |
Japanese | コウジョウセンホルモンホジュウリョウホウ, 甲状腺ホルモン補充療法 |
Czech | Léčba substituce tyreoidálních hormonů |
Portuguese | Hormonoterapia de substituição da tiróide |
Italian | Terapia di sostituzione di ormoni tiroidei |
French | Hormonothérapie thyroïdienne substitutive |
Hungarian | Pajzsmirigy hormonhelyettesítő terápia |